Abstract
Despite the emergence of new diagnostic and therapeutic methods, invasive fungal infections are still a major cause of morbidity and mortality in immunocompromised and critical patients. Therefore, adjuvant treatments to the standard antifungal therapy are being investigated, with immunity-based therapy being one of the most important. Both immunomodulatory (dendritic and T cells transfusions, colony stimulating factors, interferón-gamma, interleukin 12, fungal vaccines, transfer factors and certain drugs such as chloroquine) and immunotherapeutic modalities (granulocyte transfusions, monoclonal antibodies and intravenous immunoglobulin) have been described. This document aims to summarise currently available data on immunity-based therapy of fungal infections and to provide basic knowledge on the immune response to fungal infections. This helps to understand how, in selected cases, immunity-based therapy may improve the response to standard antifungal treatment. The potential indications of immunity-based therapy in the paediatric patient are reviewed, although there is still a lack of scientific evidence for its use in children.
References
Dec 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M A Gordon, A Casadevall
Dec 1, 1996·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·P D Greenberg, J P Cello
Jan 20, 2000·Infection and Immunity·O NethM W Turner
Feb 11, 2000·The Journal of Infectious Diseases·A MencacciL Romani
Mar 18, 2000·Antimicrobial Agents and Chemotherapy·C M Kunin, W Y Ellis
May 11, 2002·AIDS·Mark A JacobsonUNKNOWN AACTG 325 Protocol Team
Mar 26, 2004·Vaccine·Ruth C Matthews, James P Burnie
Apr 20, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Donald C Sheppard, John E Edwards
Sep 17, 2004·Nature Reviews. Microbiology·Arturo CasadevallLiise-anne Pirofski
Feb 25, 2005·Antimicrobial Agents and Chemotherapy·Robert A LarsenWilliam E Dismukes
May 27, 2005·British Journal of Haematology·Shmuel Shoham, Stuart M Levitz
May 27, 2005·British Journal of Haematology·Charalampos Antachopoulos, Emmanuel Roilides
Aug 23, 2005·Medical Mycology·S BellocchioL Romani
Jan 20, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Brahm H SegalLuigina Romani
Apr 19, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jan PachlUNKNOWN Mycograb Invasive Candidiasis Study Group
May 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas J SmithAntonio C Wolff
Aug 18, 2006·Journal of Medical Microbiology·Yasuaki ArataniHideki Koyama
Jun 29, 2007·The Journal of Infectious Diseases·Lars TramsenThomas Lehrnbecher
Jan 29, 2008·The Lancet Infectious Diseases·Antonio Cassone
Apr 10, 2008·Scandinavian Journal of Immunology·M Hamad
Aug 13, 2008·Bone Marrow Transplantation·M G SeidelH Einsele
Dec 20, 2008·BMC Microbiology·Eveline C van AsbeckJan Verhoef
Oct 16, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jonathan LambourneThomas S Harrison
Citations
Mar 2, 2010·Médecine sciences : M/S·Jean-Christophe TortosaGrégoire Moutel
Jan 1, 2011·Revista de psiquiatrí́a y salud mental·Francisco Javier Sanz-FuentenebroErnesto Verdura Vizcaíno
Nov 30, 2014·Revista de psiquiatrí́a y salud mental·Rosana Guerrero-DomínguezIgnacio Jiménez